Finance

In this article

Pedestrians walk past a Gap Inc. store in Shanghai, China.
Qilai Shen | Bloomberg | Getty Images

Check out the companies making headlines in midday trading.

Gap – The retailer popped 10% after beating Wall Street’s estimates for revenue. Gap also also gave a cautious outlook for the holiday season.

Palo Alto Networks – Shares of the cybersecurity provider added 6.5% after beating expectations for revenue and per-share earnings, according to Refinitiv.

Ross Stores – Shares shot up 15% following the discount retailer’s report of beats on per-share earnings and revenue for the latest quarter.

Live Nation – The Ticketmaster parent gained nearly 3% following Ticketmaster’s announcement that it would not hold its previously scheduled general sale of tickets for Taylor Swift’s “Eras” tour on Friday. The announcement followed fans’ rebukes over site malfunctions and long waits during the presale on top of calls from public officials to break up the duo because of anti-trust concerns.

StoneCo – Shares of the financial technology company jumped 12% after its quarterly adjusted net income beat consensus estimates, according to FactSet. Revenue was also slightly higher than analysts predicted.

Keysight Technologies – The electronic design company added 4.2% after it reported beating FactSet’s expectations for revenue and per-share earnings. Keysight also said those indicators will be either in-line or above expectations for the next quarter. Management said it had record orders in the quarter and fiscal year.

Applied Materials – Shares rose 3.4% after the manufacturer known for its semiconductor offerings beat analysts’ estimates on revenue and earnings for its fiscal fourth quarter.

Articles You May Like

What investors need to consider when choosing a dividend-paying fund
Home Depot’s sales are improving, but it says consumers are still cautious about spending
BlackRock expands its tokenized money market fund to Polygon and other blockchains
China’s Alibaba releases AI search tool for small businesses in Europe and the Americas
Amgen says no concerns around weight loss drug’s bone density data after stock falls